CytomX Therapeutics, Inc.
—- Market cap
- —
- Debt
- +$2.99M
- Cash
- −$292.06M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CTMX stock price vs PEG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PEG's multiple
Needs PEG P/S.
Implied fair value · at CTMX's multiple
Needs CTMX P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CTMX FY 2025 (ended Dec 31, 2025) · PEG FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
CytomX Therapeutics, Inc. · implied price per share
Bear
$0.44
Base
$0.52
Bull
$0.60
Public Service Enterprise Group Incorporated · implied price per share
Bear
$22.24
Base
$26.17
Bull
$30.09
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.03x
1.38x
Net debt / EBITDA
Leverage against operating earnings
20.51x
5.36x
Cash and equivalents
Liquid reserves on the balance sheet
$292.06M
$317.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
IDEAYA Biosciences, Inc.
CTMX vs IDYA
EXELIXIS, INC.
CTMX vs EXEL
GILEAD SCIENCES, INC.
CTMX vs GILD
AMGEN INC
CTMX vs AMGN
AbbVie Inc.
CTMX vs ABBV
BRISTOL MYERS SQUIBB CO
CTMX vs BMY
Duke Energy CORP
CTMX vs DUK
AMERICAN ELECTRIC POWER CO INC
CTMX vs AEP
NEXTERA ENERGY INC
CTMX vs NEE
SOUTHERN CO
CTMX vs SO
CONSOLIDATED EDISON INC
CTMX vs ED
NATIONAL FUEL GAS CO
CTMX vs NFG
$2.99M
$23.42B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.